Chronic diabetic peripheral neuropathic pain: psychometric properties of pain and physical function outcome measures

References

• Treede RD. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology. 2008;70(18):1630.
   PubMed Web of Science ®Google Scholar
• Haanpää M, Backonja MM, Bennett MI, et al. Assessment of neuropathic pain in primary care. Am J Med. 2009;122:S13–S21.
   PubMed Web of Science ®Google Scholar
• Cherry CL, Skolasky RL, Lal L, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology. 2006;66(6):867–873.
   PubMed Web of Science ®Google Scholar
• Haanpaa M, Lockwood DN, Hietaharju A. Neuropathic pain in leprosy. Lepr Rev. 2004;75(1):7–18.
   PubMed Web of Science ®Google Scholar
• Lacoux P, Ford N. Treatment of neuropathic pain in Sierra Leone. Lancet Neurol. 2002;1(3):190–195.
   PubMed Web of Science ®Google Scholar
• Clinical Resource Efficiency Support Team. Guidelines on the management of neuropathic pain [Internet]. 2008. [cited 2018 Sep 6] Available from: http://www.thblack.com/links/RSD/CRESTManagementNeuropathicPainGuidelines.pdf
   Google Scholar
• Dobson JL, McMillan J, Li L. Benefits of exercise intervention in reducing neuropathic pain. Front Cell Neurosci. 2014;8:102.
   PubMed Web of Science ®Google Scholar
• Jack M, Wright D. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Transl Res. 2012;159(5):355–365.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293.
   PubMed Web of Science ®Google Scholar
• Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106(3):337–345.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17(8):1010–1018.
   PubMed Web of Science ®Google Scholar
• Haanpää M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152(1):14–27.
   PubMed Web of Science ®Google Scholar
• Mehta P, Claydon L, Hendrick P, et al. Outcome measures in randomized-controlled trials of neuropathic pain conditions: a systematic review of systematic reviews and recommendations for practice. Clin J Pain. 2015;31(2):169–176.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129–138.
   PubMedGoogle Scholar
• Physician Consortium for Performance Improvement. Measures Development, Methodology, and Oversight Advisory Committee: Recommendations to PCPI Work Groups on Outcome Measure. 2011.
   Google Scholar
• Mehta P, Mani R, Claydon L, et al. Pain and physical functioning in neuropathic pain: a systematic review of psychometric properties of various outcome measures. Pain Prac. 2015;16(4):495–508.
   PubMed Web of Science ®Google Scholar
• Bot S, Terwee C, van der Windt D, et al. Clinimetric evaluation of shoulder disability questionnaires: a systematic review of the literature. Ann Rheum Dis. 2004;63(4):335–341.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis. 1986;39(11):897–906.
   PubMedGoogle Scholar
• Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1–2):9–19.
   PubMed Web of Science ®Google Scholar
• Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18(6):343–349.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60(11):1524–1534.
   PubMed Web of Science ®Google Scholar
• Radbruch L, Loick G, Kiencke P, et al. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage. 1999;18(3):180–187.
   PubMed Web of Science ®Google Scholar
• Badia X, Muriel C, Gracia A, et al. Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain [Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica]. Med Clin. 2003;120(2):52–59.
   PubMed Web of Science ®Google Scholar
• Ger LP, Ho ST, Sun WZ, et al. Validation of the Brief Pain Inventory in a Taiwanese population. J Pain Symptom Manage. 1999;18(5):316–322.
   PubMed Web of Science ®Google Scholar
• Mendoza T, Mayne T, Rublee D, et al. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006;10(4):353–361.
   PubMed Web of Science ®Google Scholar
• Salsa Collaborative Study Group, Ebenso J, Fuzikawa P, et al. The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes. Disabil Rehabil. 2007;29(9):689–700.
   PubMed Web of Science ®Google Scholar
• Mehta P, Claydon L, Mani R, et al. Investigating the psychometric properties of patient reported outcome measures in individuals with chronic diabetic neuropathic pain: prospective longitudinal cohort study protocol. Phy Ther Rev. 2014;19(6):440–446.
   Google Scholar
• Biernacki P, Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Sociol Methods Res. 1981;10(2):141–163.
   Web of Science ®Google Scholar
• Bennett MI, Smith BH, Torrance N, et al. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6(3):149–158.
   PubMed Web of Science ®Google Scholar
• Merskey H, Bogduk N. Classification of chronic pain, part III: pain terms, a current list with definitions and notes on usage 2nd ed. Seattle (WA): IASP Press; 2011.
   Google Scholar
• Salsa Collaborative Study Group, Ebenso, J., Fuzikawa, P., Melchior, H., Wexler, R., Piefer, A., … Velema, J. P. The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes. Disabil Rehabil. 2007;29(9), 689–700. doi: 10.1080/09638280600926587.
   Web of Science ®Google Scholar
• Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27(1):26–35.
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251.
   PubMed Web of Science ®Google Scholar
• de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229.
   PubMed Web of Science ®Google Scholar
• Schaefer DR, Don AD. Development of a standard E-mail methodology: results of an experiment. Public Opin. 1998;62(3):378–397.
   Web of Science ®Google Scholar
• Field A. Discovering statistics using IBM SPSS statistics. 4th ed. London: SAGE Publications Ltd; 2013.
   Google Scholar
• Fleiss JL. Design and analysis of clinical experiments. New York: John Wiley & Sons; 2011.
   Google Scholar
• Chen HM, Chen CC, Hsueh IP, et al. Test-retest reproducibility and smallest real difference of 5 hand function tests in patients with stroke. Neurorehabil Neural Repair. 2009;23(5):435–440.
   PubMed Web of Science ®Google Scholar
• Portney LG, Watkins MP. Foundations of clinical research – applications to practice. 3rd revised United States ed. Upper Saddle River (NJ): Prentice Hall; 2007.
   Google Scholar
• Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56(5):395–407.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132(6):2087–2102.
   PubMed Web of Science ®Google Scholar
• Wijk U, Brandsma JW, Dahlstrom O, et al. The concurrent validity of the Amharic version of Screening of Activity Limitation and Safety Awareness (SALSA) in persons affected by leprosy. Lepr Rev. 2013;84(1):13–22.
   PubMed Web of Science ®Google Scholar
• Melchior H, Velema J. A comparison of the Screening Activity Limitation and Safety Awareness (SALSA) scale to objective hand function assessments. Disabil Rehabil. 2011;33(21–22):2044–2052.
   PubMed Web of Science ®Google Scholar
• Beaton DE, Bombardier C, Katz JN, et al. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol. 2001;28(2):400–405.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Roorda LD, Dekker J, et al. Mind the MIC: large variation among populations and methods. J Clin Epidemiol. 2010;63(5):524–534.
   PubMed Web of Science ®Google Scholar
• Stratford PW, Binkley J, Solomon P, et al. Defining the minimum level of detectable change for the Roland-Morris questionnaire. Phys Ther. 1996;76(4):359–365; discussion 66–68.
   PubMed Web of Science ®Google Scholar
• van der Roer N, Ostelo RW, Bekkering GE, et al. Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain. Spine (Phila Pa 1976). 2006;31(5):578–582.
   PubMed Web of Science ®Google Scholar
• Cella D, Eton DT, Lai J, et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24(6):547–561.
   PubMed Web of Science ®Google Scholar
• Eton DT, Cella D, Yost KJ, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57(9):898–910.
   PubMed Web of Science ®Google Scholar
• Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med. 1998;17(1):101–110.
   PubMed Web of Science ®Google Scholar
• Ebenso J, Velema JP. Test-retest reliability of the Screening Activity Limitation and Safety Awareness (SALSA) scale in North-West Nigeria. Lepr Rev. 2009;80(2):197–204.
   PubMed Web of Science ®Google Scholar